A detailed history of Hall Laurie J Trustee transactions in Pfizer Inc stock. As of the latest transaction made, Hall Laurie J Trustee holds 33,683 shares of PFE stock, worth $846,453. This represents 0.31% of its overall portfolio holdings.

Number of Shares
33,683
Previous 31,246 7.8%
Holding current value
$846,453
Previous $875,000 11.43%
% of portfolio
0.31%
Previous 0.3%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$27.7 - $31.39 $67,504 - $76,497
2,437 Added 7.8%
33,683 $975,000
Q2 2024

Jul 22, 2024

SELL
$25.26 - $29.6 $22,683 - $26,580
-898 Reduced 2.79%
31,246 $875,000
Q1 2024

Apr 23, 2024

SELL
$25.89 - $29.73 $29,773 - $34,189
-1,150 Reduced 3.45%
32,144 $892,000
Q4 2023

Jan 11, 2024

SELL
$26.13 - $33.94 $13,065 - $16,970
-500 Reduced 1.48%
33,294 $959,000
Q3 2023

Oct 12, 2023

SELL
$32.09 - $37.51 $19,254 - $22,506
-600 Reduced 1.74%
33,794 $1.12 Million
Q4 2022

Jan 11, 2023

SELL
$41.75 - $54.5 $6,471 - $8,447
-155 Reduced 0.45%
34,394 $1.76 Million
Q3 2022

Oct 11, 2022

SELL
$43.76 - $53.42 $3,063 - $3,739
-70 Reduced 0.2%
34,549 $1.51 Million
Q3 2020

Oct 09, 2020

SELL
$31.75 - $37.25 $34,290 - $40,230
-1,080 Reduced 3.03%
34,619 $1.27 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $17,019 - $19,315
517 Added 1.47%
35,699 $1.4 Million
Q3 2019

Oct 25, 2019

SELL
$32.49 - $42.13 $9,552 - $12,386
-294 Reduced 0.83%
35,182 $1.26 Million
Q1 2019

May 02, 2019

SELL
$37.5 - $41.2 $35,512 - $39,016
-947 Reduced 2.6%
35,476 $1.51 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $37,162 - $42,368
-966 Reduced 2.58%
36,423 $1.53 Million
Q1 2018

May 10, 2018

SELL
$31.91 - $37.02 $14,423 - $16,733
-452 Reduced 1.19%
37,389 $1.33 Million
Q2 2017

Aug 22, 2017

BUY
N/A
37,841
37,841 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hall Laurie J Trustee Portfolio

Follow Hall Laurie J Trustee and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

News

Stay updated on Hall Laurie J Trustee with notifications on news.